Empowering

Clinical Research

Across the MENA Region

ClinVice is a Trusted SMO/CRO in the MENA Region

Bringing Extensive Experience in Partnering with both Global Pharmaceutical Leaders and Emerging Biotech Innovators.

ClinVice Combines

Global Quality Standards with Regional Insight

To deliver Trusted, Efficient, and Compliant Clinical Research Solutions across The MENA Region

ClinVice

A Dynamic and Innovative Site Management Organization (SMO) and Full-Service Clinical Research Organization (CRO) dedicated to advancing Clinical Research across The MENA Region.

 

We Partner

With Global and Regional Pharmaceutical, Biotechnology, and Healthcare Organizations to deliver High-Quality Clinical Trial Solutions that accelerate The Development of Life-Saving Therapies.

About ClinVice

Mission

To Advance Healthcare in The MENA Region
By delivering World-Class Clinical Research Solutions that Connect Patients with Life-Changing Therapies.

Vision

To be the Leading Center of Excellence
For Clinical Research and Site Management in The MENA Region— Bridging Global Standards with Regional Strengths.

Leadership

At ClinVice, Our Strength Lies in Our People.

Our Multidisciplinary Team of Experts – Including 
Clinical Operations Specialists, Regulatory Affairs Professionals, Data Managers, and Quality Auditors—Brings decades of Combined Experience in Global and Regional Trials.
We believe in Continuous Learning, Collaboration, and Scientific Excellence to deliver results that truly make a difference.

Our Services

We Offer Tailored Clinical Trial Services

Our Services Empower Pharmaceutical Companies, Biotech Firms, and International CROs to Efficiently Conduct High-Quality Trials across The MENA Region.

Through Our Three Strategic Branches

SMO Services

Patient Recruitment, Operational Oversight, Regulatory Coordination, and Staff Support.

CRO Services

End-to-end Clinical Trial Lifecycle — Feasibility, Start-Up, Monitoring, Data Management, and Closeout.

Training Academy

ClinVice Clinical Trial Training Academy Empowers Investigators, Coordinators, and Monitors with Specialized Programs.

ClinVice

Your Trusted Partner for Clinical Research

Excellence in The MENA Region

Why Choose Us ?

🔵 Bilingual Operations (English & Arabic)

🔵 Deep Regulatory Knowledge across MENA

🔵 Strategic Consulting for Trial Optimization

🔵 Pre-Qualified Investigator Networks

🔵Comprehensive Site and Staff Training Programs

🔵 Proven Track Record in Multinational Studies

🔵 Global Standards with Local Expertise

Our Experience

With Years of Proven Expertise

ClinVice has Successfully supported Numerous Trials across Therapeutic Areas in The MENA Region.

Our Experienced Team Ensures :

Operational Excellence, Patient Safety, and Data Integrity—Delivering Results that meet Global Standards while addressing Regional Healthcare Needs.

Successful Trials or Clinical Trials
0%
MENA Countries
0%
Sites
0%

Our Team Provides

Expert Consultation on Study Design Regulatory Pathways & Operational Execution
Ensuring alignment with both Sponsor Priorities and Regional Healthcare Needs
Actively Seek
We Actively Seek Meaningful Collaborations across The MENA Region and Globally with
  • Pharmaceutical 
  • Biotechnology Companies
  • Academic Institutions
  • Healthcare Organizations
Through Strategic Partnerships
We aim to Co-Develop High-Impact Clinical Research Hubs in The Region and accelerate Clinical Research Capacity Building
 

 

 

 
 
Building Collaborative Networks
To Advance Clinical Research in The MENA Region and Beyond
 
 
 
 
 
 
 

Our Consultant

QUSAI AL-SHARE

Research Consultant

PHARMD.,PHD

Partnering with Us

Stakeholders Gain Access to A Trusted Regional Network & Scientific Expertise

Commitment to Improving Patient Outcomes through Innovation

End to end Clinical Trial Services in The MENA Region

Whether you're a Sponsor, CRO, or Clinical Research Professional

ClinVice is your Trusted Regional Partner

ClinVice Newsletter Signup Form

Subscribe to ClinVice Newsletter

Sign up in the newsletter form below to receive the latest news and updates from our company.